Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
insider trading reports,buying,selling,purchases Stock Analysis Form 4 Filings Insider Buys Significant Buys Penny Stocks
Insider Buying 		Insider Sales
Insider Buy Sell Ratios Stock Options Insider Trading
Stock Screener 		Insider Trading
Graph View 		Insider Watch

Insider Trading - Albers Jeffrey W.

Select Time period:
Enter Stock Symbol or Cik: Cik Lookup...
Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for Albers Jeffrey W.

Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2018-08-06
Sale		 2018-08-08
4:08 pm		 Blueprint Medicines Corp BPMC Albers Jeffrey W.
CEO		 20,000 $70.59 $1,411,897 935,034
(Direct)		 View
2018-05-07
Sale		 2018-05-09
4:29 pm		 Blueprint Medicines Corp BPMC Albers Jeffrey W.
CEO		 20,000 $78.9 $1,578,091 955,034
(Direct)		 View
2018-03-02
Sale		 2018-03-06
4:55 pm		 Blueprint Medicines Corp BPMC Albers Jeffrey W.
CEO		 20,000 $92.57 $1,851,463 975,034
(Direct)		 View
2017-11-06
Sale		 2017-11-08
4:21 pm		 Blueprint Medicines Corp BPMC Albers Jeffrey W.
CEO		 30,000 $70.31 $2,109,251 825,034
(Direct)		 View
2017-08-07
Sale		 2017-08-09
6:18 pm		 Blueprint Medicines Corp BPMC Albers Jeffrey W.
CEO		 30,000 $49.62 $1,488,637 18,272
(Direct)		 View
2017-06-28
Sale		 2017-06-30
6:18 pm		 Blueprint Medicines Corp BPMC Albers Jeffrey W.
CEO		 20,000 $50.47 $1,009,394 47,920
(Direct)		 View
2017-03-14
Sale		 2017-03-16
5:35 pm		 Blueprint Medicines Corp BPMC Albers Jeffrey W.
CEO		 20,000 $40.03 $800,516 56,466
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2018-08-06
Exercise		 2018-08-08
4:08 pm		 N/A
N/A		 Blueprint Medicines Corp BPMC Albers Jeffrey W.
CEO		 20,000 $1.87 935,034
(Direct)		 View
2018-08-06
Exercise		 2018-08-08
4:08 pm		 N/A
2024-07-30		 Blueprint Medicines Corp BPMC Albers Jeffrey W.
CEO		 20,000 $1.87 935,034
(Direct)		 View
2018-06-25
Conversion		 2018-06-27
4:27 pm		 N/A
N/A		 Magenta Therapeutics Inc. MGTA Albers Jeffrey W.
Director		 4,152 $0 4,152
(Direct)		 View
2018-06-25
Conversion		 2018-06-27
4:27 pm		 N/A
N/A		 Magenta Therapeutics Inc. MGTA Albers Jeffrey W.
Director		 10,729 $0 4,152
(Direct)		 View
2018-05-07
Exercise		 2018-05-09
4:29 pm		 N/A
N/A		 Blueprint Medicines Corp BPMC Albers Jeffrey W.
CEO		 20,000 $1.87 955,034
(Direct)		 View
2018-05-07
Exercise		 2018-05-09
4:29 pm		 N/A
2024-07-30		 Blueprint Medicines Corp BPMC Albers Jeffrey W.
CEO		 20,000 $1.87 955,034
(Direct)		 View
2018-03-02
Exercise		 2018-03-06
4:55 pm		 N/A
N/A		 Blueprint Medicines Corp BPMC Albers Jeffrey W.
CEO		 20,000 $1.87 975,034
(Direct)		 View
2018-03-02
Exercise		 2018-03-06
4:55 pm		 N/A
2024-07-30		 Blueprint Medicines Corp BPMC Albers Jeffrey W.
CEO		 20,000 $1.87 975,034
(Direct)		 View
2018-02-16
Option Award		 2018-02-20
5:29 pm		 N/A
2028-02-16		 Blueprint Medicines Corp BPMC Albers Jeffrey W.
CEO		 170,000 $81.44 995,034
(Direct)		 View
2017-11-06
Exercise		 2017-11-08
4:21 pm		 N/A
N/A		 Blueprint Medicines Corp BPMC Albers Jeffrey W.
CEO		 24,514 $1.87 825,034
(Direct)		 View
2017-11-06
Exercise		 2017-11-08
4:21 pm		 N/A
2024-07-30		 Blueprint Medicines Corp BPMC Albers Jeffrey W.
CEO		 24,514 $1.87 825,034
(Direct)		 View
2017-02-16
Option Award		 2017-02-21
4:27 pm		 N/A
2027-02-16		 Blueprint Medicines Corp BPMC Albers Jeffrey W.
CEO		 170,000 $36.05 849,548
(Direct)		 View